Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Egle

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Justus Liebigs Annalen Der Chemie|April 1, 1972
[Polyols derived from sterols and sterol derivatives. VI. Steroids containing structural units of the ecdyson and elatericines]H Lettré, J Greiner, K Rutz, et al.
American Journal of Clinical Pathology|February 9, 2000
Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia. A comparison of three semiquantitation techniquesI Marschitz, I Tinhofer, A Hittmair, et al.
Cancer Research|November 1, 1991
Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35F Uberall, K Maly, A Egle, et al.
Blood|May 30, 1998
Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemiaI Tinhofer, I Marschitz, M Kos, et al.
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Cancer Research|August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cellsA Villunger, A Egle, M Kos, et al.
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
International Journal of STD & AIDS|June 18, 2011
Raltegravir in pregnancy: a case series presentationN Taylor, V Touzeau, M Geit, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)J Gruber, F Geisen, R Sgonc, et al.
Leukemia Research|May 24, 2017
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experienceM Leisch, L Weiss, N Lindlbauer, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Justus Liebigs Annalen Der Chemie|April 1, 1972
[Polyols derived from sterols and sterol derivatives. VI. Steroids containing structural units of the ecdyson and elatericines]H Lettré, J Greiner, K Rutz, et al.
American Journal of Clinical Pathology|February 9, 2000
Analysis of Bcl-2 protein expression in chronic lymphocytic leukemia. A comparison of three semiquantitation techniquesI Marschitz, I Tinhofer, A Hittmair, et al.
Cancer Research|November 1, 1991
Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35F Uberall, K Maly, A Egle, et al.
Blood|May 30, 1998
Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemiaI Tinhofer, I Marschitz, M Kos, et al.
European Journal of Immunology|December 1, 1996
Modulation of Apo-1/Fas (CD95)-induced programmed cell death in myeloma cells by interferon-alpha 2A Egle, A Villunger, M Kos, et al.
Cancer Research|August 15, 1997
Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cellsA Villunger, A Egle, M Kos, et al.
British Journal of Haematology|May 1, 1997
Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional statusA Egle, A Villunger, I Marschitz, et al.
International Journal of STD & AIDS|June 18, 2011
Raltegravir in pregnancy: a case series presentationN Taylor, V Touzeau, M Geit, et al.
Stem Cells (Dayton, Ohio)|May 1, 1996
2',2'-Difluorodeoxycytidine (gemcitabine) induces apoptosis in myeloma cell lines resistant to steroids and 2-chlorodeoxyadenosine (2-CdA)J Gruber, F Geisen, R Sgonc, et al.
Leukemia Research|May 24, 2017
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experienceM Leisch, L Weiss, N Lindlbauer, et al.
Pageof 4